Your Biopharmaceutical Development and Manufacturing Partner

Nanotherapeutics, Inc. Concludes Type C Meeting with the U.S. Food and Drug Administration - November 2013

Nanotherapeutics, Inc. announced today that on November 20, 2013, the Company held a Type C meeting with the U.S. Food and Drug Administration (“FDA”), providing an opportunity for the FDA to review and provide feedback on Nanotherapeutics’ plans for its Advanced Development and Manufacturing (NANO-ADM) Center facility to be located in Copeland Park, Alachua, FL.

Full Article

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.